Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OXTR | P30559 | 20/20 | 0.52 |
| ▸ | AVPR2 | P30518 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14410319 | 1.00 | OXTR (0.52) | OXTRAVPR2 | |
| SCHEMBL5435717 | 1.00 | OXTR (0.52) | OXTRAVPR2 | |
| SCHEMBL5438198 | 0.88 | OXTR (0.55) | OXTRAVPR2 | |
| SCHEMBL14410318 | 0.88 | OXTR (0.55) | OXTRAVPR2 | |
| SCHEMBL14417278 | 0.85 | OXTR (0.67) | OXTRAVPR2 | |
| SCHEMBL5439344 | 0.85 | OXTR (0.67) | OXTRAVPR2 | |
| SCHEMBL14410322 | 0.85 | OXTR (0.67) | OXTRAVPR2 | |
| SCHEMBL1597826 | 0.83 | OXTR (0.73) | OXTRAVPR2 | |
| SCHEMBL9975178 | 0.83 | OXTR (0.73) | OXTRAVPR2 | |
| SCHEMBL16531863 | 0.83 | OXTR (0.73) | OXTRAVPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070208031-A1 | Substituted Diketopiperazines as Oxytocin Antagonists | BORTHWICK ALAN D | 2007-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070208031-A1 | Substituted Diketopiperazines as Oxytocin Antagonists | OXTR, AVPR2, PRLHR | OXTR 1/4885AVPR2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.